Overweight and obesity. Overweight and obesity
Conditions
Interventions
Intervention 1: Intervention group: participants will receive 500 mg Persian shallot daily, for 8 weeks. participants will take part in a free online preventive intervention with the aim of promoting
Sponsors
National Institute of Medical Research Development of Iran
Eligibility
Sex/Gender
All
Age
10 Years to 18 Years
Inclusion criteria
Inclusion criteria: Children and adolescents aged 10-18 years Body Mass Index equal to or higher than the age- and sex-specific 85th percentile
Exclusion criteria
Exclusion criteria: Subjects with endocrine disorders Individuals with any physical disability Those using mineral and/or vitamin supplements History of chronic diseases and/or chronic medication use Individuals under special diets History of smoking, alcohol, and drug abuse
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total antioxidant capacities. Timepoint: At the beginning of the intervention to 8 weeks after intervention. Method of measurement: Human Total antioxidant capacity (TAOC)ELISA Kit.;Reactive oxygen species. Timepoint: At the beginning of the intervention to 8 weeks after intervention. Method of measurement: ROS assay kit and DCFDA fluorimetry. | — |
Secondary
| Measure | Time frame |
|---|---|
| Anthropometric indices. Timepoint: At the beginning of the intervention to 8 weeks after intervention. Method of measurement: Height will be measured by trained nutritionist to the nearest 0.1 cm with a portable stadiometer (SECA, Hamburg, Germany) without shoes. Weight will be measured to the nearest 0.1 kg with a balanced portable digital weight scale (SECA, Hamburg, Germany) with light indoor clothing and no shoes. Body mass index (BMI) will be calculated as weight (kg)/height2 (m). Waist circumference (WC) will be measured over the unclothed abdomen at the narrowest point between the rib cage and the superior border of the iliac crest using a nonelastic flexible tape to the nearest 0.1 cmHip circumference (HC) will be measured at the widest part of the hip at the level of the greater trochanter to the nearest 0.1 cm. Wrist circumference (WrC) will be measured to the nearest 0.1 cm on the dominant arm using a tape meter. Neck circumference (NC) will be measured with the most prominent portion of the thyroid cartilage taken as a landmark to the nearest 0.1 cm. Waist-Height Ratio (WHtR), and Waist-hip ratio (WHR), Abdominal Volume Index (AVI), Conicity Index (CI), and A Body Shape Index (ABSI) will be calculated using the following formulas:WHR: WC (cm) / HC (cm)WHtR: WC (cm) / Height (cm)AVI: (2 × WC2 (cm2) + 0.7 × [WC (cm) – HC (cm)]2) / 1000CI: WC (m) / 0.109 × v(Weight(kg) )/v(Height(m) )ABSI: WC/(BMI 2/3 Height 1/2).;Body composition. Timepoint: At the beginning of the intervention to 8 weeks after intervention. Method of measurement: Bioelectrical impedance analysis will be perfumed by InBody 720 Body Composition Analyzer (BioSpace Co., Ltd., Seoul, Korea). Sex, age, and height will be entered directly into the instrument prior to the impedance measure. Bare feet will be placed on the metal plates of the scale and the participant firmly grasp the hand grips while placing the thumb and fingers in the standard location as indicated in the operation manual. Th | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMotahar Heidari-Beni
Esfahan University of Medical Sciences
Outcome results
None listed